{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:12:08Z","timestamp":1781993528978,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jvacx.2023.100362","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T16:29:45Z","timestamp":1690907385000},"page":"100362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Post-marketing safety surveillance of the rotavirus vaccine in India"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-564X","authenticated-orcid":false,"given":"Gagandeep","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Lakhkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanraj","family":"Bhamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Dharmadhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Narwadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Kanujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus S.","family":"Poonawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2023.100362_b0005","doi-asserted-by":"crossref","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136-41.","DOI":"10.1016\/S1473-3099(11)70253-5"},{"issue":"62 Suppl 2","key":"10.1016\/j.jvacx.2023.100362_b0010","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"World Health Organization-Coordinated Global Rotavirus Surveillance Network. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000\u20132013","volume":"1","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"32 Suppl 1","key":"10.1016\/j.jvacx.2023.100362_b0015","doi-asserted-by":"crossref","first-page":"A5","DOI":"10.1016\/j.vaccine.2014.03.004","article-title":"Rotavirus gastroenteritis in India, 2011\u20132013: revised estimates of disease burden and potential impact of vaccines","volume":"11","author":"John","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100362_b0020","unstructured":"Available online from https:\/\/www.merckvaccines.com\/Products\/RotaTeq\/Pages\/home."},{"key":"10.1016\/j.jvacx.2023.100362_b0025","unstructured":"Available online from https:\/\/www.gsksource.com\/pharma\/content\/gsk\/source\/us\/en\/brands\/rotarix\/pi\/po.html."},{"key":"10.1016\/j.jvacx.2023.100362_b0030","unstructured":"Available online from https:\/\/www.bharatbiotech.com\/images\/press\/Bharat_Biotech 2015_pressrelease.pdf."},{"key":"10.1016\/j.jvacx.2023.100362_b0035","unstructured":"Available online from http:\/\/www.path.org\/news\/press-room\/860\/."},{"issue":"7","key":"10.1016\/j.jvacx.2023.100362_b0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pds.3800","article-title":"Post-marketing monitoring of intussusception after rotavirus vaccination in Japan","volume":"24","author":"Bauchau","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100362_b0045","doi-asserted-by":"crossref","first-page":"e0144812","DOI":"10.1371\/journal.pone.0144812","article-title":"Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants","volume":"11","author":"Leino","year":"2016","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.jvacx.2023.100362_b0050","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2016.04.050","article-title":"The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation","volume":"34","author":"Stowe","year":"2016","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.jvacx.2023.100362_b0055","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMc1402790","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Noel","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100362_b0060","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4161\/hv.28857","article-title":"Rotavirus vaccines: current status and future considerations","volume":"10","author":"Yen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2023.100362_b0065","unstructured":"WHO. Information sheet. Observed rate of vaccine reactions rotavirus vaccine. June 2018. Available online from https:\/\/cdn.who.int\/media\/docs\/default-source\/pvg\/global-vaccine-safety\/rotavirus-vaccine-rates-information-sheet-0618.pdf?sfvrsn=fdd3cc44_4&download=true."},{"key":"10.1016\/j.jvacx.2023.100362_b0070","unstructured":"WHO. Global Vaccine Safety: Statement on risks and benefits of rotavirus vaccines Rotarix and RotaTeq. Available online on http:\/\/www.who.int\/vaccine_safety\/committee\/topics\/rotavirus\/rotarix_and_rotateq\/statement_May_2015\/en\/."},{"issue":"45","key":"10.1016\/j.jvacx.2023.100362_b0075","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jvacx.2023.100362_b0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"issue":"52","key":"10.1016\/j.jvacx.2023.100362_b0085","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1016\/j.vaccine.2018.11.006","article-title":"A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"36","author":"Rathi","year":"2018","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.jvacx.2023.100362_b0090","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1016\/j.vaccine.2018.07.064","article-title":"Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine","volume":"36","author":"Desai","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100362_b0095","unstructured":"Global rotavirus vaccine options expand with World Health Organization prequalification of new vaccine from India. September 27, 2018 by PATH. Available online at https:\/\/www.path.org\/media-center\/global-rotavirus-vaccine-options-expand-world-health-organization-prequalification-new-vaccine-india\/."},{"issue":"8","key":"10.1016\/j.jvacx.2023.100362_b0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(22)00161-X","article-title":"Safety and immunogenicity of the Rotavac and ROTASIIL rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial","volume":"22","author":"Kanungo","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"s1","key":"10.1016\/j.jvacx.2023.100362_b0105","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1086\/605045","article-title":"Population-based incidence of intussusception and a case-control study to examine the association of intussusception with natural rotavirus infection among indian children","volume":"200","author":"Bahl","year":"2009","journal-title":"J Infect Dis"},{"issue":"32 Suppl 1","key":"10.1016\/j.jvacx.2023.100362_b0110","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.vaccine.2014.03.028","article-title":"Intussusception in southern India: comparison of retrospective analysis and active surveillance","volume":"11","author":"Jehangir","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jvacx.2023.100362_b0115","doi-asserted-by":"crossref","first-page":"e68482","DOI":"10.1371\/journal.pone.0068482","article-title":"Childhood intussusception: a literature review","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100362_b0120","doi-asserted-by":"crossref","first-page":"e001061","DOI":"10.1136\/bmjpo-2021-001061","article-title":"Childhood immunisations in India during the COVID-19 pandemic","volume":"5","author":"Shet","year":"2021","journal-title":"BMJ Paediatr Open"},{"issue":"12","key":"10.1016\/j.jvacx.2023.100362_b0125","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.vaccine.2018.02.024","article-title":"Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults","volume":"36","author":"Anil","year":"2018","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.jvacx.2023.100362_b0130","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.vaccine.2019.03.067","article-title":"Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants","volume":"37","author":"Kawade","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T07:09:02Z","timestamp":1719990542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"alternative-id":["S2590136223001031"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100362","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-marketing safety surveillance of the rotavirus vaccine in India","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100362"}}